|search over 1,000 Venture Capital related sites|
|1.||Bay City Capital - Client Transaction Advisory Services (100%):|
Client List As a life sciences merchant bank, Bay City Capital offers a variety of advisory services to its clients and portfolio companies. These services include strategic partnering (e.g., mergers, acquisitions, technology licensing, marketing/distribution agreements, etc.) and financing activit...
|2.||Bay City Capital - General Life Sciences Fund (99%):|
Portfolio Bay City Capital’s Life Sciences Funds represent $365 million in committed capital that has been invested in 42 companies: Bay City Capital Fund I, L. P. Formed in 1997 $115,000,000 Bay City Capital Fund II, L. P. Formed in 1999 $100,000,000 Bay City Capital Fund III, L. P. Formed i...
|3.||Bay City Capital - Professional Staff (94%):|
Michelle M. Buran joined Bay City Capital as an Analyst in 2004. She performs company research, compiles market information, and develops financial analyses. Prior to joining Bay City Capital, Ms. Buran worked as a trading assistant and analyst for Pioneer Capital, a private investment firm. Ms. Bu...
|4.||Bay City Capital - Professional Staff (89%):|
Kim Trahan is an Analyst at Bay City Capital and joined the company in 2004. She provides support for the company’s venture activities through collecting market information, building financial models and tracking industry trends. In addition, Ms. Trahan participates in several investment team...
|5.||Bay City Capital Company Profile (75%):|
Bay City Capital LLC (Bay City Capital) was established in 1997 as an equal partnership between The Craves Group LLC and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry and related activities. Since that date, we’ve managed...
|6.||Bay City Capital (73%):|
Since 1997, Bay City Capital has acted as the exclusive investment advisor to four funds representing $476 million in committed capital that has been invested in 50 companies. Three of these funds are life sciences funds, representing $365 million in committed capital. In addition, we serve as the ...
|7.||Aberdare :: Naheed Ismaili (71%):|
Naheed Ismaili joined Aberdare Ventures from Bay City Capital, a leading life sciences merchant bank. At Bay City Capital, she evaluated numerous investment opportunities in biopharmaceuticals and assisted portfolio companies in their fundraising activities. She was also heavily involved in transfor...
|8.||Bay City Capital (70%):|
Bay City Capital’s understanding of capital markets and its access to a world-wide network of scientific and industry expertise comes from the collective experience of its own investment team. Our managing directors, partners and venture partners have played significant leadership roles in a ...
|9.||5AM Ventures - Leadership - Partners (69%):|
Andrew J. Schwab Founder and Managing Partner Prior to founding 5AM Ventures in 2002, Mr. Schwab was a Principal at Bay City Capital. After joining Bay City Capital in 1999, Mr. Schwab led many of the firm s investment and merchant banking activities for such companies as Cubist, Lombard Odier, Meta...
|10.||5AM Ventures - Leadership - Partners (69%):|
Carin M. Rollins Principal Mrs. Rollins was previously an Investment Manager at Bay City Capital, where she was involved with a number of the firm s early-stage investments and participated on a number of portfolio company Boards. Prior to Bay City Capital, Mrs. Rollins was an Associate with Booz-Al...
|11.||Bay City Capital - Directors (69%):|
Fred Craves, PhD , is founder and Managing Director of Bay City Capital. Dr. Craves chairs BCC's Executive Committee and serves on its Board of Directors. Prior to founding Bay City Capital, Dr. Craves spent over 20 years leading and managing biotechnology and pharmaceutical companies. He was Execu...
|12.||Bay City Capital - Venture Partners (69%):|
Jeanne Cunicelli is a Partner at Bay City Capital and has been with the company since 1998. Her investment activities focus on medical device, drug delivery and drug development companies. Ms. Cunicelli joined Bay City Capital from Ernst & Young's International Life Sciences Group where she man...
|13.||Bay City Capital - Principals (69%):|
Kirby Bartlett is Chief Administrative Officer at Bay City Capital where he works on a variety of investing activities. He has been involved in 15 investments, including Chemdex and Lexicon, and in numerous strategic financings and partnerships for portfolio companies such as Reliant Pharmaceutical...
|14.||Bay City Capital - Professional Staff (65%):|
Stacey M. Leanos joined Bay City Capital as an Analyst in 2002. She performs company research, compiles market information, tracks industry trends and develops financial analyses. Ms. Leanos is on five investment teams in BCC's general life sciences funds. She received a BA in Finance and Business ...
|15.||Bay City Capital - Professional Staff (65%):|
Michael E. Masterson is an Analyst at Bay City Capital. Mr. Masterson is responsible for developing financial analyses and conducting research for the firm's venture investments and related activities. He also creates opportunity analyses and industry studies for projects within BCC's portfolio. Mr...
|16.||Bay City Capital - Directors (65%):|
Brian Cunningham joined The Pritzker Organization in July 2004 as an Associate. Dr. Cunningham is primarily responsible for matters related to Bay City Capital. He was previously a Consultant with L.E.K. Consulting, specializing in the biopharmaceutical and medical device sectors. Prior to joining ...
|17.||Bay City Capital - Principals (59%):|
Judy Koh is a CPA and Chief Financial Officer at Bay City Capital. She is responsible for the financial operations and the accounting and tax reporting of all BCC entities. Ms. Koh served as Chief Financial Officer of Montgomery Capital from 1992 to 1998. Previously, she was Accounting Manager at J...
|18.||5AM Ventures - Company Profile (58%):|
5AM Ventures makes seed and early-stage investments in next-generation life science companies. Founded in 2002 by former Bay City Capital principals, 5AM Ventures has offices in Boston and San Francisco. As successful former company leaders and established venture capitalists, the 5AM Team take a ha...
|19.||Bay City Capital - Venture Partners (57%):|
Lionel Carnot is a senior investment professional at Bay City Capital where he focuses on investment opportunities in specialty pharmaceuticals, drug development companies and diagnostics, as well as European investment opportunities. Mr. Carnot joined Bay City Capital in March 2005 after five year...
|20.||Bay City Capital - NANAF (57%):|
Portfolio Bay City Capital serves as the Investment Advisor to the $111 Million North American Nutrition and Agriculture Fund (NANAF). Formed in 1999, NANAF, along with its European and Australian sister funds, operates under the umbrella of the Gilde Food & Agribusiness Fund. NANAF invests in ...